iBLOOD retweeted
Proud to present our newest paper in CELL STEM CELL: Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML! cell.com/cell-stem-cell/full…
Forschende vom DKFZ & @hi_stem_lab haben einen zentralen Mechanismus entschlüsselt, der zum Therapieversagen bei der akuten myeloischen Leukämie beiträgt. Die Entdeckung schafft eine wichtige Grundlage für präzisere & erfolgreichere Behandlungsstrategien.
t1p.de/r50a2
Scientists from DKFZ & @hi_stem_lab deciphered a key mechanism that contributes to treatment failure in acute myeloid leukemia (AML). This discovery lays an important foundation for more precise and long-term successful treatment strategies. @CellStemCell
t1p.de/brfxf
Für seine Forschung, die die Therapie von Patient:innen mit Metastasen bei unbekanntem Primärtumor (CUP-Syndrom) verbessern kann, erhält Alwin Krämer vom DKFZ und dem Universitätsklinikum Heidelberg den Paul-Martini-Preis 2026. 👏
t1p.de/3mpq5
iBLOOD retweeted
Congratulations - very well deserved! After a long time time - significant advances in CUP. A milestone!
Für seine Forschung, die die Therapie von Patient:innen mit Metastasen bei unbekanntem Primärtumor (CUP-Syndrom) verbessern kann, erhält Alwin Krämer vom DKFZ und dem Universitätsklinikum Heidelberg den Paul-Martini-Preis 2026. 👏
t1p.de/3mpq5
It’s a wrap! #SCC2025HD concluded after three days of wonderful talks, discussions and presentations. Heartful thanks to all speakers, participants and chairs. See you next time in Heidelberg! 👋👋👋
iBLOOD retweeted
A mind-blowing unpublished work on clonal mosaicism presented today by @Goodell_Lab at #SCC2025HD 🔥@hi_stem_lab
#SCC2025HD is just around the corner. We are looking forward to welcoming the participants at our exciting 12th International Heidelberg Symposium on Stem Cells and Cancer.
iBLOOD retweeted
Great day at #SCC2025HD in Heidelberg. Big applause to Trumpp lab @hi_stem_lab for their inspiring presentations during the #AML workshop 👏🏼
iBLOOD retweeted
Thank you, BCUK for supporting our very first PPIE event at Imperial College. A step forward to address a key gap by ensuring that research is informed by, and responsive to, the perspectives of those most affected. Look forward. @LisaWhittaker02 @BloodCancer_Res @ImperialImmuno
We’re delighted to be sponsoring this #PPIE event. Our Research Involvement Lead @LisaWhittaker02 is attending, more info 👇🏻
🧬 Plasticity is an emerging hallmark of leukemic stem cells.
How can cutting-edge single-cell multi-omics help us to unravel it and overcome therapy resistance in AML?
Our new review by @frankhuangmd , Andreas Trumpp & @pstelmach_md authors.elsevier.com/c/1ljC1…
iBLOOD retweeted
📢 Recruitment for the EMBL International PhD Programme is officially open!
At EMBL, we train young scientists to become skilled and creative future leaders in academia and other sectors. Join us and get a head start on your career in life sciences!
embl.org/about/info/embl-int…
iBLOOD retweeted
🚨Job Alert!
🔬 PhD Position in Bioinformatics! Join my group at Heidelberg University to study AML dormancy & therapy resistance using multi-omics & single-cell data.
📷Apply or share: karriere.klinikum.uni-heidel…
🚨 Here you can read the interview (in German) with our Managing Director Andreas Trumpp about our recent paper in Nature on the role of neurons in pancreatic cancer.
rnz.de/region/heidelberg_art…
We provide 4 Travel Fellowships of €500 to enable early-career researchers to attend 12th International Heidelberg Symposium on Stem Cells and Cancer. 🚗🚄✈️ #SCC2025
More Info at: stem-cells-cancer.de
Don't miss the Keynote Lecture by Prof. Elaine Fuchs from the Rockefeller University at the 12th International Heidelberg Symposium on Stem Cells and Cancer. #SCC2025
Abstract Deadline: 15 July 2025
Registration Deadline: 1 August 2025
More Info: stem-cells-cancer.de/
Don't miss the Keynote Lecture by Prof. Andrew Wei from the Peter MacCallum Cancer Center at the 12th International Heidelberg Symposium on Stem Cells and Cancer. #SCC2025
Abstract Deadline: 15 July 2025
Registration Deadline: 1 August 2025
More Info: stem-cells-cancer.de
Great line of speakers in 12th International Heidelberg Symposium on Stem Cells and Cancer. #SCC2025
Register to meet the top experts in stem cells and cancer fields.
More Info: stem-cells-cancer.de/
Abstract Deadline: 15 July 2025
Registration Deadline: 1 August 2025
Registration still open! 🚨
Come and join us in the 12th International Heidelberg Symposium on Stem Cells and Cancer.
Abstract Deadline: 15 July 2025
Registration Deadline: 1 August 2025
More Info: stem-cells-cancer.de/
Don't miss Keynote Lecture by Prof. Scott Armstrong from the Dana-Farber Cancer Institute at the 12th International Heidelberg Symposium on Stem Cells and Cancer. #SCC2025
Abstract Deadline: 15 July 2025
Registration Deadline: 1 August 2025
More Info: stem-cells-cancer.de





























